However, systemic IFN-γ levels were significantly greater in the CT26/HER2 tumor-bearing mice than in the naive controls, 4T1.2/HER2 tumor-cured, and 4T1.2/HER2 tumor-bearing mice, which displayed similar IFN-γ levels (Figure 5C). This evidence concerns the gene IFNG and neoplasm.